High defibrillation threshold in patients with implantable defibrillator: how effective is the subcutaneous finger lead?

European Journal of Cardio-thoracic Surgery

Volumn 35, Issue 3, 2009, Pages 489-492

  Osswald, Brigitte R ^a   De Simone, Raffaele ^b   Most, Sabine ^b   Tochtermann, Ursula ^b   Tanzeem, Ahmed ^b   Karck, Matthias ^b  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Defibrillation threshold; ICD; Ventricular arrhythmia

Indexed keywords

ADULT; AGED; ARTICLE; BIOMEDICAL ENGINEERING; DEFIBRILLATOR; FEMALE; FINGER; HEART VENTRICLE FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PACEMAKER ELECTRODE; PATIENT SAFETY; PRIORITY JOURNAL; SUBCUTANEOUS TISSUE;

AGED; ARRHYTHMIAS, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; EQUIPMENT DESIGN; EQUIPMENT SAFETY; FEMALE; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 60849084436     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2008.10.021     Document Type: Article

References (18)

1. Zipes D.P., Wyse D.G., Friedman P.L., Epstein A.E., Hallstrom A.P., Greene H.L., Schron E.B., Domanski M., and for the Antiarrhythmics versus Implantable Defibrillator (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med 337 (1997) 1576-1583
2. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.E., Bioneau R., Domanski M., Troutman C., Anderson J., Johnson G., Mc Nulty S.E., Clapp-Channing N., Davidson-Ray L.D., Fraulo E.S., Fishbein D.P., Luceri R.M., and Ip J.H. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
3. Russo A.M., Sauer W., Gerstenfeld E.P., Hsia H.H., Lin D., Cooper J.M., Dixit S., Verdino R.J., Nayak H.M., Callans D.J., Patel V., and Marchlinski F.E. Defibrillation threshold test: is it really necessary at the time of implantable cardioverter-defibrillator insertion?. Heart Rhythm 2 (2005) 456-461
4. Trusty J.M., Hayes D.L., Stanton M.S., and Friedman P.A. Factors affecting the frequency of subcutaneous lead usage in implantable defibrillators. Pacing Clin Electrophysiol 23 (2000) 842-846
5. Gold M.R., Khalighi K., Kavesh N.G., Daly B., Peters R.W., and Shorofsky S.R. Clinical predictors of transvenous biphasic defibrillation thresholds. Am J Cardiol 79 (1997) 1623-1627
6. Khalighi K., Daly B., Leino E.V., Shorofsky S.R., Kavesh N.G., Peters R.W., and Gold M.R. Clinical predictors of transvenous defibrillation energy requirements. Am J Cardiol 79 (1997) 150-153
7. Shepard R.K., DeGroot P.J., Pacifico A., Wood M.A., and Ellenbogen K.A. Prospective randomized comparison of 65%/65% versus 42%/42% tilt biphasic waveform on defibrillation threshold in humans. J Interv Card Electrophysiol 8 (2003) 221-225
8. Block M., Hammel D., Böcker D., Borggrefe M., Budde T., Isbruch F., Scheld H.H., and Breithardt G. Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size. Pacing Clin Electrophysiol 19 (1996) 207-214
9. Block M., Hammel D., Böcker D., Borggrefe M., Budde T., Isbruch F., Scheld H.H., and Breithardt G. Transvenous-subcutaneous defibrillation leads: effect of transvenous electrode polarity on defibrillation threshold. J Cardiovasc Electrophysiol 5 (1994) 912-918
10. Chen J., Naseem R.H., Obel O., and Joglar J.A. Habitual cocaine use is associated with high defibrillation threshold during ICD implantation. J Cardiovasc Electrophysiol 18 (2007) 722-725
11. Weinbroun A.A., Glick A., Copperman Y., Yashar T., Rudick V., and Flaishon R. Halothane, isoflurane, and fentanyl increase the minimally effective defibrillation threshold of an implantable cardioverter defibrillator: first report in humans. Anesth Analg 95 (2002) 1147-1153
12. Iskos D., Lock K., Lurie K.G., Fahy G.J., Petersen-Stejskal S., and Benditt D.G. Submuscular versus subcutaneous pectoral implantation of cardioverter defibrillators: effect on high voltage pathway impedance and defibrillation efficacy. J Interv Card Electrophysiol 2 (1998) 47-52
13. Sandstedt B., Kennergren C., and Edvardsson N. Bidirectional defibrillation using implantable defibrillators: a prospective randomized comparison between pectoral and abdominal active generators. Pacing Clin Electrophysiol 24 (2001) 1343-1353
14. Winter J., Zimmermann N., Lidolt H., Dees H., Perings C., Vester E.G., Poll L., Schipke J.D., Contzen K., and Gams E. Optimal method to achieve consistently low defibrillation energy requirements. Am J Cardiol 86 Suppl. (2000) 71K-75K
15. Obadia J.F., Janier M., Chevalier P., Bazillais O., Chassignolie J.F., Kirkorian G., and Touboul P. Defibrillation threshold and electrode configurations: an experimental study testing three configurations in twelve pigs. J Cardiovasc Surg (Torino) 38 (1997) 495-499
16. Usui M., Walcott G.P., KenKnight B.H., Walker R.G., Rollins D.L., Smith W.M., and Ideker R.E. Influence of malpositioned transvenous leads on defibrillation efficacy with and without a subcutaneous array electrode. Pacing Clin Electrophysiol 18 (1995) 2008-2016
17. Gradaus R., Block M., Seidl K., Brunn J., Isgro F., Hammel D., Hauer B., Breithardt G., and Bocker D. Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II. J Cardiovasc Electrophysiol 12 (2001) 921-927
18. Kettering K., Mewis C., Dörnberger V., Vonthein R., Bosch R.F., Sepiel L., and Kühlkamp V. Long-term experience with subcutaneous ICD leads: a comparison among three different types of subcutaneous leads. Pacing Clin Electrophysiol 27 (2004) 1355-1361